Controversy: Are we ready to treat inflammation for ASCVD prevention?

In this controversy, Prof. Paul Ridker and Prof. Ulrich Laufs brilliantly review the state of the art regarding the challenges of treating inflammation to prevent ischemic cardiovascular complications. The aim of the discussion is to address the question: Is the current knowledge consistent enough to initiate such treatments in addition to the existing therapeutic tools?

The controversy is divided into three parts: two 15-minute lectures and an open discussion with the audience.

Paul Ridker

Director of the Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital and the Eugene Braunwald Professor of Medicine at Harvard School of Medicine

Ulrich Laufs

Chair and Professor of Cardiology at Leipzig University, Germany

Cookies
We use cookies. If you think that's OK, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. You can change your settings from our Cookie Policy page.
Save Accept all

Report

Contains abusive or derogatory content
Contains mature or sensitive content
Contains misleading or false information
Contains spam, fake content or potential malware
Harassment or bullying behavior

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .